Works by Hosomi, Yukio

Results: 101
    1
    2
    3
    4
    5

    A Phase II Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 1, p. 85, doi. 10.1016/j.cllc.2023.09.006
    By:
    • Shinji Nakamichi;
    • Kaoru Kubota;
    • Kotone Matsuyama;
    • Toshihiro Misumi;
    • Toshiyuki Kozuki;
    • Shunichi Sugawara;
    • Katsuhiko Naoki;
    • Nobuaki Kobayashi;
    • Takehito Shukuya;
    • Tsuneo Shimokawa;
    • Masashi Ishihara;
    • Hiroshi Wakui;
    • Yukio Hosomi;
    • Hiroshi Tanaka;
    • Haruhiro Saito;
    • Shinobu Hosokawa;
    • Yuichi Takiguchi;
    • Takashi Kasai;
    • Hiroshi Nokihara;
    • Ryo Morita
    Publication type:
    Article
    6

    A Phase I/II Study of Necitumumab Plus Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non--Small Cell Lung Cancer Study: (NEJ048A/NEXUS).

    Published in:
    Clinical Lung Cancer, 2023, v. 24, n. 4, p. 371, doi. 10.1016/j.cllc.2023.01.008
    By:
    • Akihiko Miyanaga;
    • Hajime Asahina;
    • Satoshi Watanabe;
    • Takehito Shukuya;
    • Yukari Tsubata;
    • Yukio Hosomi;
    • Shunichi Sugawara;
    • Makoto Maemondo;
    • Tetsuya Okano;
    • Satoshi Morita;
    • Kotone Matsuyama;
    • Kunihiko Kobayashi;
    • Masahiro Seike
    Publication type:
    Article
    7

    Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung C ancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.

    Published in:
    Clinical Lung Cancer, 2022, v. 23, n. 7, p. 585, doi. 10.1016/j.cllc.2022.08.011
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Atsushi Nakamura;
    • Shunichiro Iwasawa;
    • Hiroshige Yoshioka;
    • Yasuhiro Goto;
    • Masafumi Takeshita;
    • Toshiyuki Harada;
    • Katsuya Hirano;
    • Tetsuya Oguri;
    • Masashi Kondo;
    • Satoru Miura;
    • Yukio Hosomi;
    • Terufumi Kato;
    • Toshio Kubo;
    • Junji Kishimoto;
    • Nobuyuki Yamamoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Journal Article
    21

    Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    Investigational New Drugs, 2013, v. 31, n. 5, p. 1275, doi. 10.1007/s10637-013-9941-z
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Article
    22

    Erratum to: Pemetrexed and carboplatin followed by pemetrexed maintenance therapy in chemo-naïve patients with advanced nonsquamous non-small-cell lung cancer.

    Published in:
    2013
    By:
    • Okamoto, Isamu;
    • Aoe, Keisuke;
    • Kato, Terufumi;
    • Hosomi, Yukio;
    • Yokoyama, Akira;
    • Imamura, Fumio;
    • Kiura, Katsuyuki;
    • Hirashima, Tomonori;
    • Nishio, Makoto;
    • Nogami, Naoyuki;
    • Okamoto, Hiroaki;
    • Saka, Hideo;
    • Yamamoto, Nobuyuki;
    • Yoshizuka, Naoto;
    • Sekiguchi, Risa;
    • Kiyosawa, Kazuhiro;
    • Nakagawa, Kazuhiko;
    • Tamura, Tomohide
    Publication type:
    Correction Notice
    23
    24

    Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.

    Published in:
    2017
    By:
    • Yuki Misumi;
    • Hiroaki Okamoto;
    • Jiichiro Sasaki;
    • Noriyuki Masuda;
    • Mari Ishii;
    • Tsuneo Shimokawa;
    • Yukio Hosomi;
    • Yusuke Okuma;
    • Makoto Nagamata;
    • Takashi Ogura;
    • Terufumi Kato;
    • Masafumi Sata;
    • Sakiko Otani;
    • Akira Takakura;
    • Koichi Minato;
    • Yosuke Miura;
    • Takuma Yokoyama;
    • Saori Takata;
    • Katsuhiko Naoki;
    • Koshiro Watanabe
    Publication type:
    journal article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    A case of diffuse pulmonary ossification.

    Published in:
    Respirology Case Reports, 2021, v. 9, n. 8, p. 1, doi. 10.1002/rcr2.812
    By:
    • Yomota, Makiko;
    • Kamei, Tina;
    • Mirokuji, Kie;
    • Hishima, Tsunekazu;
    • Hosomi, Yukio
    Publication type:
    Article
    47

    Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carboplatin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas.

    Published in:
    Clinical Lung Cancer, 2024, v. 25, n. 4, p. 389, doi. 10.1016/j.cllc.2024.02.002
    By:
    • Yusuke Okuma;
    • Shogo Nomura;
    • Jun Sakakibara-Konishi;
    • Yoko Tsukita;
    • Shuji Murakami;
    • Yukio Hosomi;
    • Yuichi Tambo;
    • Yoshihito Kogure;
    • Hiroshige Yoshioka;
    • Motohiro Tamiya;
    • Kiichiro Ninomiya;
    • Eiji Iwama
    Publication type:
    Article
    48

    Treatment Rationale and Design for J-AXEL: A Randomized Phase 3 Study Comparing Nab-Paclitaxel With Docetaxel in Patients With Previously Treated Advanced Non—Small-Cell Lung Cancer.

    Published in:
    Clinical Lung Cancer, 2017, v. 18, n. 1, p. 100, doi. 10.1016/j.cllc.2016.08.003
    By:
    • Yasuto Yoneshima;
    • Satoshi Morita;
    • Masahiko Ando;
    • Satoru Miura;
    • Hiroshige Yoshioka;
    • Tetsuya Abe;
    • Terufumi Kato;
    • Masashi Kondo;
    • Yukio Hosomi;
    • Katsuyuki Hotta;
    • Nobuyuki Yamamoto;
    • Junji Kishimoto;
    • Yoichi Nakanishi;
    • Isamu Okamoto
    Publication type:
    Article
    49
    50